These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 26733555)

  • 21. Concordance with NCCN treatment guidelines: Relations with health care utilization, cost, and mortality in breast cancer patients with secondary metastasis.
    Rocque GB; Williams CP; Kenzik KM; Jackson BE; Azuero A; Halilova KI; Ingram SA; Pisu M; Forero A; Bhatia S
    Cancer; 2018 Nov; 124(21):4231-4240. PubMed ID: 30317547
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Guideline-Concordant Treatment Among Elderly Women With HER2-Positive Metastatic Breast Cancer in the United States.
    Vyas AM; Aroke H; Kogut S
    J Natl Compr Canc Netw; 2020 Apr; 18(4):405-413. PubMed ID: 32259787
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug use evaluation of tamoxifen focusing on off-label use in a managed care population in Israel.
    Kahan NR; Waitman DA; Blackman S; Vardy DA
    J Manag Care Pharm; 2010 Jun; 16(5):355-9. PubMed ID: 20518588
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incidence and Outcome of Breast Biopsy Procedures During Follow-up After Treatment for Breast Cancer.
    van la Parra RFD; Liao K; Smith BD; Yang WT; Leung JWT; Giordano SH; Kuerer HM
    JAMA Surg; 2018 Jun; 153(6):559-568. PubMed ID: 29387884
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neutropenia-related costs in patients treated with first-line chemotherapy for advanced non-small cell lung cancer.
    Stokes ME; Muehlenbein CE; Marciniak MD; Faries DE; Motabar S; Gillespie TW; Lipscomb J; Knopf KB; Buesching DP
    J Manag Care Pharm; 2009 Oct; 15(8):669-82. PubMed ID: 19803556
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Breast MRI utilization in older patients with newly diagnosed breast cancer.
    Sommer CA; Stitzenberg KB; Tolleson-Rinehart S; Carpenter WR; Carey TS
    J Surg Res; 2011 Sep; 170(1):77-83. PubMed ID: 21658724
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative Effectiveness of Chemotherapy Regimens in Prolonging Survival for Two Large Population-Based Cohorts of Elderly Adults with Breast and Colon Cancer in 1992-2009.
    Du XL; Zhang Y; Parikh RC; Lairson DR; Cai Y
    J Am Geriatr Soc; 2015 Aug; 63(8):1570-82. PubMed ID: 26200214
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Limited validity of diagnosis codes in Medicare claims for identifying cancer metastases and inferring stage.
    Chawla N; Yabroff KR; Mariotto A; McNeel TS; Schrag D; Warren JL
    Ann Epidemiol; 2014 Sep; 24(9):666-72, 672.e1-2. PubMed ID: 25066409
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between adjuvant chemotherapy and risk of acute kidney injury in elderly women diagnosed with early-stage breast cancer.
    Li S; Liu J; Virnig BA; Collins AJ
    Breast Cancer Res Treat; 2017 Feb; 161(3):515-524. PubMed ID: 27933451
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Survival, healthcare resource use and costs among stage IV ER + breast cancer patients not receiving HER2 targeted therapy: a retrospective analysis of linked SEER-Medicare data.
    Lang K; Huang H; Sasane M; Paly VF; Hao Y; Menzin J
    BMC Health Serv Res; 2014 Jul; 14():298. PubMed ID: 25008431
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of Outcomes Associated With the Use of Newly Approved Oncology Drugs in Medicare Beneficiaries.
    Green AK; Curry M; Trivedi N; Bach PB; Mailankody S
    JAMA Netw Open; 2021 Feb; 4(2):e210030. PubMed ID: 33625507
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of off-label use of oral oncolytics at a community cancer center.
    Kalis JA; Pence SJ; Mancini RS; Zuckerman DS; Ineck JR
    J Oncol Pract; 2015 Mar; 11(2):e139-43. PubMed ID: 25604593
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disparities in Use of Human Epidermal Growth Hormone Receptor 2-Targeted Therapy for Early-Stage Breast Cancer.
    Reeder-Hayes K; Peacock Hinton S; Meng K; Carey LA; Dusetzina SB
    J Clin Oncol; 2016 Jun; 34(17):2003-9. PubMed ID: 27069085
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of treatment of early-stage breast cancer among Nurses' Health Study participants and other Medicare beneficiaries.
    Austin AM; Kapadia NS; Brooks GA; Onega TL; Eliassen AH; Tamimi RM; Holmes M; Wang Q; Grodstein F; Tosteson ANA
    Breast Cancer Res Treat; 2019 Apr; 174(3):759-767. PubMed ID: 30607634
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Off-label drug use in oncology: a systematic review of literature.
    Saiyed MM; Ong PS; Chew L
    J Clin Pharm Ther; 2017 Jun; 42(3):251-258. PubMed ID: 28164359
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Initial Trends in the Use of the 21-Gene Recurrence Score Assay for Patients With Breast Cancer in the Medicare Population, 2005-2009.
    Dinan MA; Mi X; Reed SD; Hirsch BR; Lyman GH; Curtis LH
    JAMA Oncol; 2015 May; 1(2):158-66. PubMed ID: 26181015
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Delayed initiation of adjuvant chemotherapy in older women with breast cancer.
    Smith-Graziani D; Lei X; Giordano SH; Zhao H; Karuturi M; Chavez-MacGregor M
    Cancer Med; 2020 Oct; 9(19):6961-6971. PubMed ID: 32767723
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of Sociodemographic, Clinical, and Genomic Factors Associated With Breast Cancer Mortality in the Linked Surveillance, Epidemiology, and End Results and Medicare Database.
    Robinson TJ; Wilson LE; Marcom PK; Troester M; Lynch CF; Hernandez BY; Parrilla E; Brauer HA; Dinan MA
    JAMA Netw Open; 2021 Oct; 4(10):e2131020. PubMed ID: 34714340
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Temporal and geographic variation in the use of hematopoietic growth factors in older women receiving breast cancer chemotherapy: findings from a large population-based cohort.
    Du XL; Lairson DR; Begley CE; Fang S
    J Clin Oncol; 2005 Dec; 23(34):8620-8. PubMed ID: 16314624
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Population-based assessment of hospitalizations for toxicity from chemotherapy in older women with breast cancer.
    Du XL; Osborne C; Goodwin JS
    J Clin Oncol; 2002 Dec; 20(24):4636-42. PubMed ID: 12488407
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.